Clincosm LogoSign in Get a demo

Brain Tumor Treatment Satisfaction Survey

Sponsor
Methodist Healthcare (Other)
Overall Status
Completed
CT.gov ID
NCT00557375
Collaborator
(none)
105
Enrollment
1
Location
21
Actual Duration (Months)
5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Patients with recent diagnosis and treatment of a brain tumor will complete a short questionnaire concerning the patient's quality of life and emotional state since receiving treatment. Caregivers will complete a one-page questionnaire concerning the patient's quality of life and emotional state since receiving treatment.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients with a recent diagnosis and treatment of a brain tumor (primary or metastatic; N=105, 61% female, 39% male) were identified in the clinics of Semmes-Murphey Neurologic and Spine Institute or the Methodist University Hospital in Memphis, TN. Caregivers were recruited from among relatives and friends who provide the most day-to-day care to the patient. All participants were between 3 months and 1 year from their most recent brain tumor treatment. Participants were given a simple, 5-point based survey to asses treatment-specific satisfaction, patient education, posttreatment quality of life, and pre- and post-treatment emotional impact. Therapeutic modalities surveyed include: surgery, external beam radiotherapy, whole-brain radiotherapy, stereotactic radiosurgery, and chemotherapy.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    105 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Treatment Satisfaction Survey for Brain Tumor Patients and Their Caregivers
    Actual Study Start Date :
    Jun 1, 2007
    Actual Primary Completion Date :
    Mar 1, 2009
    Actual Study Completion Date :
    Mar 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Brain tumor patients
    2

    Caregivers of brain tumor patients

    Outcome Measures

    Primary Outcome Measures

    1. Overall satisfaction and emotional impact of treatments in patients who have undergone therapy(s)for brain tumors. [(greater than or equal to 3 months) from first treatment for brain tumor]

    Secondary Outcome Measures

    1. Observational data about the treatment course and emotional well-being of the brain tumor patient as provided by the caregiver. [(Greater than or equal to 3 months) from first treatment for brain tumor]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • Patients who are between 3 months and one year out from treatment for their brain tumor

    • Karnofsky Performance Status (KPS) >= 60

    • Age 18 years or over, any gender, any race

    • "patient caregivers will be individuals who provide the most day-to-day care for their respective brain tumor patients

    Exclusion Criteria:
    • No exclusions

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Methodist University Hospital Memphis Tennessee United States 38104

    Sponsors and Collaborators

    • Methodist Healthcare

    Investigators

    • Principal Investigator: Jeffrey M. Sorenson, MD, Methodist Healthcare

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Methodist Healthcare
    ClinicalTrials.gov Identifier:
    NCT00557375
    Other Study ID Numbers:
    • MHIRB 2007-036
    First Posted:
    Nov 14, 2007
    Last Update Posted:
    Apr 11, 2022
    Last Verified:
    Apr 1, 2022
    Keywords provided by Methodist Healthcare
    Brain Tumors
    Survey
    Additional relevant MeSH terms:
    Brain Neoplasms

    Study Results

    No Results Posted as of Apr 11, 2022